Lennox-Gastaut Syndrome Across the Continuum: Optimizing Seizure and Non-Seizure Outcomes from Pediatrics to Adulthood
Released On
September 15, 2025
Expires On
September 15, 2026
Media Type
Internet
Completion Time
60 minutes
Specialty
Neurology, Pediatrics
Topic(s)
Epilepsy
This activity is joinly provided by Partners for Advancing Clinical Education and Iridium Continuing Education.
This activity is supported by an educational grant from Jazz Pharmaceuticals.
Credit Available
- Physicians — maximum of 1.0 AMA PRA Category 1 Credit(s)™
All other healthcare professionals completing this course will be issued a statement of participation.
Target Audience
This activity is designed for neurologists, epileptologists, pediatricians, and allied health professionals involved in the management of patients with Lennox-Gastaut Syndrome (LGS).
Program Overview
Gain practical, caregiver-informed insights from a neurologist, pediatrician, and LGS advocate in this program focused on improving recognition, treatment, and family engagement in Lennox-Gastaut Syndrome (LGS).
This program equips healthcare providers with actionable, evidence-based strategies to support individuals living with LGS and their families across the care continuum—from early childhood through adulthood.
You’ll learn how to:
- Enhance early recognition of LGS symptoms and seizure patterns
- Apply best practices in treatment planning and care transitions
- Address caregiver burden and family needs through a multidisciplinary lens
Learning Objectives
Upon completion of this activity, participants should be better able to:
- Summarize the different seizure types in LGS to improve diagnostic accuracy and treatment planning.
- Implement strategies to reduce diagnostic delays for LGS, enabling earlier intervention and improved long-term outcomes.
- Review the mechanisms of action, clinical benefits, and limitations of emerging therapies for LGS, and demonstrate how to integrate them into individualized care plans for optimal patient outcomes.
- Apply skills to educate and support caregivers in managing LGS-related challenges, with a focus on behavioral management and cognitive support throughout the care continuum.
Faculty
Elaine Wirrell, MD
Professor of Neurology
Chair of Child Neurology
Mayo Clinic
Rochester, MN
Kelsey Klaas, MD
Assistant Professor of Pediatric and Adolescent Medicine
Medical Co-Director, Pediatric Pain Rehabilitation Center
Mayo Clinic
Rochester, MN
Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by Partners for Advancing Clinical Education (Partners) and Iridium Continuing Education. Partners is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation
Partners designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosures of Conflicts of Interest
Elaine Wirrell, MD
- Independent Contractor (Including contracted research): Encoded, Grin pharma, Neurocrine
Kelsey Klaas, MD
- Nothing to Disclose
Instructions for Participation and Credit
There are no fees for participating and receiving CME credit for this enduring activity. To receive CME credit participants must:
- Read the CME/CE information and faculty disclosures.
- Participate in the online activity.
- Complete the posttest with a score of 70% or higher.
- Submit the evaluation form.
Certificates will be available for the participant to download.
Course Viewing Requirements
Supported Browsers
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above
Supported Phones & Teblets
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Contact Information
For additional information about the accreditation of this activity, please visit https://partnersed.com.